Invesco
GBT

Invesco’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Invesco’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-44,967
Closed -$3.06M – 4116
2022
Q3 		$3.06M Buy
44,967
+3,488
+8% +$192K ﹤0.01% 2454
2022
Q2 		$1.32M Buy
41,479
+1,976
+5% +$57.8K ﹤0.01% 2882
2022
Q1 		$1.37M Buy
39,503
+308
+0.8% +$9.21K ﹤0.01% 2930
2021
Q4 		$1.15M Sell
39,195
-1,577
-4% -$48.8K ﹤0.01% 3006
2021
Q3 		$1.04M Buy
40,772
+4,852
+14% +$143K ﹤0.01% 3086
2021
Q2 		$1.26M Sell
35,920
-1,853
-5% -$72.3K ﹤0.01% 3038
2021
Q1 		$1.54M Sell
37,773
-166,679
-82% -$7.66M ﹤0.01% 2879
2020
Q4 		$8.85M Sell
204,452
-352,888
-63% -$17.4M ﹤0.01% 1873
2020
Q3 		$30.7M Buy
557,340
+16,737
+3% +$1.06M 0.01% 1114
2020
Q2 		$34.1M Buy
540,603
+34,819
+7% +$2.39M 0.01% 1066
2020
Q1 		$25.8M Sell
505,784
-3,645
-0.7% -$244K 0.01% 1094
2019
Q4 		$40.5M Buy
509,429
+36,276
+8% +$2.15M 0.01% 1096
2019
Q3 		$23M Buy
473,153
+266,148
+129% +$13.9M 0.01% 1336
2019
Q2 		$10.9M Sell
207,005
-308
-0.1% -$17.7K ﹤0.01% 1706
2019
Q1 		$11M Buy
+207,313
New +$10.2M ﹤0.01% 1520
2017
Q3 		– Sell
-75,045
Closed -$2.05M – 3682
2017
Q2 		$2.05M Buy
+75,045
New +$2.23M ﹤0.01% 2534

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Invesco's GBT Position: Q4 2022 in Review

Invesco sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 44,967 shares — an estimated $3.06M sold.

Invesco first reported a position in GBT in Q2 2017 and held it in 16 quarters. The position peaked at $40.5M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Invesco reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Invesco sold 44,967 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.06M.
  • Invesco first reported a position in Global Blood Therapeutics, Inc. in Q2 2017 and held it in 16 quarters.
  • Invesco's Global Blood Therapeutics, Inc. position peaked at $40.5M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.